Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Statin Market 2019-2023 | Rising in Prevalence of Hypercholesterolemia Impacting the Market Growth | Technavio

Technavio Research
Posted on: 23 Nov 18

The global statin market 2019-2023 is expected to have an incremental growth of around $1647 million during the forecast period, according to the latest market research report by Technavio.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181123005003/en/

Technavio predicts the global statin market to post an incremental growth of around $1647 million by 2023. (Graphic: Business Wire)

A key factor driving the growth of the market is rising in the prevalence of hypercholesteremia. The major risk factor for heart diseases such as coronary heart disease, heart attack, and stroke are hypercholesteremia. The major regions affected are the US, Europe, and Asia. According to CDC, in 2012, CVDs such as heart attack and stroke were the leading causes of death in the US. Also, as per Eurostat, in 2014, over 1.8 million deaths in European regions were due to CVDs. As per an article published in NCBI, by 2030, coronary heart disease and stroke would be two leading causes of death in Asia.

This market research report on the global statin market 2019-2023 also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

In this report, Technavio highlights the increasing statin use as one of the key emerging trends in the global statin market:

Global statin market: Increasing statin use

In the US and the UK, people aged 40 years and above are recommended to monitor their cholesterol levels. Statins are considered an evidence-based treatment for high-risk patients with elevated cardiovascular risk or with a cardiovascular disorder. Prescriptions of statin have been increasing owing to the availability of low-cost generics, revise cholesterol treatment guidelines and high patient awareness of CVD.

“Globally, several awareness initiatives are underway such as the Million Hearts initiative, co-led by the CDC and the CMS, is aimed at preventing one million heart attacks and strokes in a span of five years. Such initiatives are expected to increase the patient base for statins during the forecast period.” says a senior analyst at Technavio for research on pharmaceuticals, biotechnology & life sciences.

Global statin market: Segmentation analysis

This market research report segments the global statin market by type (synthetic statins and natural statins) and geographical regions (APAC, EMEA, and the Americas).

The Americas led the market in 2018 with a market share of close to 55%, followed by EMEA and APAC respectively. The dominance of the Americas can be attributed to the growing aging population that is at high risk of lipid metabolism disorders and the increase in the incidence of chronic disorders such as diabetes and hypertension.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181123005003/en/

Business Wire
www.businesswire.com

Last updated on: 23/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.